Rchr
J-GLOBAL ID：200901060012509112
Update date: Sep. 24, 2024
Yasuaki Tamura
タムラ ヤスアキ | Yasuaki Tamura
Affiliation and department：
Job title：
Professor
Research field (1)：
Cell biology
Research keywords (1)：
腫瘍免疫学
Research theme for competitive and other funds (16)：
- 2014 - 2017 Cryo-immunology; booster effects of cryotherapy on the anti-tumor immune response
- 2012 - 2015 Developing a novel vaccine therapy targeting cancer stem cells
- 2012 - 2015 The development of combined cancer therapy targeting hypoxic microenvironment
- 2012 - 2014 腎移植拒絶反応におけるHSP90の関与についての研究
- 2011 - 2013 Potentiation of cancer immunotherapy using spatiotemporal regulation of heat shock protein-TLR ligand complex
- 2009 - 2011 Hypoxia-inducible ERO1-α acts as a member of pre-peptide loading complex and regulates immune responses in the context of MHC class I and class II molecules
- 2009 - 2011 Molecular immunopathology of human cancer stem cell
- 2007 - 2008 Induction of tumor antigen-specific CTL by Hsp90-antigen fusion DNA vaccine
- 2005 - 2006 Identification of Hsp90-specific receptor expressed on human dendritic cells and its application for cancer immunothearpy
- 2004 - 2006 Immune response and escape in human cancers
- 2003 - 2004 Cellular immunotherapy and immune-gene therapy by heat shock protein gp96 and dendritic cells
- 2003 - 2004 Development of novel antitumor immunogenetherapy using artificial cancer antigen-secreting tumors.
- 2003 - 2004 70hscの基質抗原ペプチド結合モチーフ解析
- 2000 - 2004 Human cancer vaccines
- 2002 - 2002 熱ショック蛋白質を用いた癌免疫療法の臨床応用
- 熱ショック蛋白質を用いた癌免疫療法の開発
Show all
Papers (104)：
-
Yasuaki Tamura, Akira Ito, Kazumasa Wakamatsu, Toshihiko Torigoe, Hiroyuki Honda, Shosuke Ito, Kowichi Jimbow. A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma. International Journal of Molecular Sciences. 2023. 24. 6
-
Takashi Sasaya, Terufumi Kubo, Kenji Murata, Yuka Mizue, Kenta Sasaki, Junko Yanagawa, Makoto Imagawa, Hirotaka Kato, Tomohide Tsukahara, Takayuki Kanaseki, et al. Cisplatin-induced HSF1-HSP90 axis enhances the expression of functional PD-L1 in oral squamous cell carcinoma. Cancer medicine. 2023. 12. 4. 4605-4615
-
Kazumasa Wakamatsu, Akira Ito, Yasuaki Tamura, Tokimasa Hida, Takafumi Kamiya, Toshihiko Torigoe, Hiroyuki Honda, Shosuke Ito, Kowichi Jimbow. Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development. Cancers. 2022. 14. 22
-
Yasuaki Tamura, Akira Ito, Kazumasa Wakamatsu, Takafumi Kamiya, Toshihiko Torigoe, Hiroyuki Honda, Toshiharu Yamashita, Hisashi Uhara, Shosuke Ito, Kowichi Jimbow. Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review. International Journal of Molecular Sciences. 2022. 23. 12
-
田村 保明, 米田 明弘. がん細胞の一生(ゆりかごから、成長・独り立ち)を担うHsp47の役割と治療法開発(墓場まで). Thermal Medicine. 2021. 37. Suppl. EL-2
ｍore...
MISC (99)：
-
和田朝香, 九冨五郎, 廣橋良彦, 田村保明, 島宏彰, 空閑陽子, 鳥越俊彦, 竹政伊知朗. 上皮間葉系細胞転換(EMT)促進因子を標的とする新規乳癌治療. 日本外科学会定期学術集会(Web). 2023. 123rd
-
和田朝香, 和田朝香, 廣橋良彦, 田村保明, 九冨五郎, 島宏彰, 空閑陽子, 竹政伊知朗, 鳥越俊彦. hERO1-Lαを標的としたトリプルネガティブ乳癌の新規治療戦略. 日本臨床ストレス応答学会大会抄録集. 2022. 16th
-
米田 明弘, 田村 保明. HSP47は小胞体からカルシウムの過剰放出を抑制することで膵癌細胞に抗癌剤耐性能を付与する(HSP47 confers chemoresistance on pancreatic cancer cells by inhibiting release of calcium from the endoplasmic reticulum). 日本癌学会総会記事. 2019. 78回. P-3159
-
野村尚生, 松丸尊紀, 春山知樹, 前田直良, 奥村正樹, 金村進吾, 稲葉謙次, 田村保明, 前仲勝実. 小胞体ストレス応答性酸化還元調節酵素を標的とした創薬スクリーニング. 日本生化学会大会(Web). 2019. 92nd. [2S03m-05]
-
米田明弘, 田村保明. HSP47によるヒト膵癌細胞の抗がん剤耐性能獲得機序の解明. 日本分子生物学会年会プログラム・要旨集(Web). 2019. 42nd
ｍore...
Education (2)：
- - 1985 Asahikawa Medical University
- - 1985 Asahikawa Medical College
Professional career (1)：
Association Membership(s) (3)：
Return to Previous Page
